Answers are grounded in this paper and cite their sources.
The leishmaniasis represents a spectrum of neglected diseases being responsible for millions of cases worldwide, highlighting the visceral form with a high percentage of morbidity and mortality. Glycans present in leishmania are possible targets for therapeutic drugs. Lectins are proteins that interact with carbohydrates and perform various biological activities. The objective of this research was to assess the antipromastigote efficacy of the lectin purified from Vatairea macrocarpa seeds (VML), determining whether its action is dependent on sugar-binding specificity. VML reduced the viability of Leishmania infantum promastigote with IC50 values, 24 h: IC50 = 11.44 ± 0.0 μM; 48 h: IC50 = 6.75 ± 0.0 μM; 72 h: IC50 = 4.34 ± 0.0 μM. In the presence of D-galactose, the leishmanicidal effect of VML was reversed, suggesting that VML exerts its antipromastigote effect by targeting cell surface glycans on L. infantum through carbohydrate–protein interactions. Flow cytometry analysis revealed that VML treatment significantly enhanced cytoplasmic ROS accumulation (by ∼80%) and induced membrane damage, with up to 97% of cells exhibiting propidium iodide (PI) uptake at 2 × IC50. Furthermore, VML did not cause toxicity in Raw 264.7 cells. In conclusion, these results demonstrate that VML possesses a potent antipromastigote activity mediated by glycan recognition, suggesting this lectin is a promising tool to explore carbohydrate targets in L. infantum and to support the development of future antileishmanial strategies.
No takes yet. Share an insight, caveat, or question.
Lima et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: